about
Autologous hematopoietic stem cell transplantation following high-dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomasMutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasiaDiversity and functional consequences of germline and somatic PTPN11 mutations in human disease.Juvenile myelomonocytic leukemia: molecular pathogenesis informs current approaches to therapy and hematopoietic cell transplantationNoonan syndromeRAS diseases in childrenSevere congenital thrombocytopaenia--first clinical manifestation of Noonan syndrome.Sequence Polymorphism and Intrinsic Structural Disorder as Related to Pathobiological Performance of the Helicobacter pylori CagA OncoproteinNoonan syndrome: clinical aspects and molecular pathogenesis.High-dose chemotherapy followed by autologous stem cell transplantation for metastatic rhabdomyosarcoma--a systematic review.Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas.FOXO1-FGFR1 fusion and amplification in a solid variant of alveolar rhabdomyosarcoma.Activation of multiple signaling pathways causes developmental defects in mice with a Noonan syndrome–associated Sos1 mutation.Disorders of dysregulated signal traffic through the RAS-MAPK pathway: phenotypic spectrum and molecular mechanismsAllogeneic hematopoietic stem cell transplantation and the risk for transmission of heritable malignancy.Kit-Shp2-Kit signaling acts to maintain a functional hematopoietic stem and progenitor cell pool.Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation.Human somatic PTPN11 mutations induce hematopoietic-cell hypersensitivity to granulocyte-macrophage colony-stimulating factor.Functional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cells.The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/myeloproliferative disease.Mediating ERK 1/2 signaling rescues congenital heart defects in a mouse model of Noonan syndrome.Peripheral blood cells from children with RASopathies show enhanced spontaneous colonies growth in vitro and hyperactive RAS signaling.Shp2 and Pten have antagonistic roles in myeloproliferation but cooperate to promote erythropoiesis in mammalsHaematology of Down syndromeFunctional evaluation of circulating hematopoietic progenitors in Noonan syndromeJuvenile myelomonocytic leukemia and chronic myelomonocytic leukemia.Juvenile myelomonocytic leukemia: a report from the 2nd International JMML Symposium.Noonan, Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway.Negative regulation of Stat3 by activating PTPN11 mutants contributes to the pathogenesis of Noonan syndrome and juvenile myelomonocytic leukemia.Noonan syndrome - a new survey.Cancer-related genes in the transcription signature of facioscapulohumeral dystrophy myoblasts and myotubes.Isolation of a distinct class of gain-of-function SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumors.DMD transcripts in CRL-2061 rhabdomyosarcoma cells show high levels of intron retention by intron-specific PCR amplification.Genetics and variation in phenotype in Noonan syndrome.Pulmonary Vasculitis and a Horseshoe Kidney in Noonan Syndrome.
P2860
Q24234049-76D72052-7ACB-4A31-B84E-2D016C5C3A79Q24301631-7919B5EE-E663-4EB8-A532-C82DDB150227Q24540529-3691F4C6-CE94-4734-AD5A-17A071E6B868Q26851000-4A7DB451-407D-4FC6-BD72-C7460D98E199Q27001641-3496CF0C-E75A-481A-A20F-3B894F7F684DQ28252058-68C8B551-7C3B-4669-893B-A458E1B4E26DQ33401274-B535CD3E-DD3B-4180-8607-230152CD352EQ33612053-CEC53C5D-9F6D-4C56-80A9-FC8B8EBB0DC8Q33806161-291454A2-7828-40AA-B134-4D00A7464FBAQ33836798-3DE98F90-8820-4CD4-AAA5-AF52830DEE47Q34132964-D7B2BB4F-1FDF-4967-91A2-F2635ED5DFE3Q34191937-9D62BDFB-726C-4629-914A-2B3572EF6FF8Q34360215-C507F8BF-2A3A-43DE-BF34-E1FC0F5BA248Q34440570-17AE766B-6313-4A5A-84A8-2B7D2777DB9BQ34698814-494FCF48-7EF9-4F65-B1CD-EF5C7A1B29D0Q35029942-9CF5F56E-628C-4AAF-811D-D3472E976398Q35212696-3EFD76FF-80BF-4F06-9065-E9AA0AEBA944Q35847470-EA517256-F765-45B1-A592-D3B183648AE0Q35847802-9BA2A3CB-CD31-4D01-B04A-D6C92CB48F6EQ35847884-88C94127-A6C9-4078-AA83-6F13C1E522C8Q35879519-F7D28F60-BE0C-438D-9D84-7553AC99690FQ35921878-BF5E8EA7-95BA-4CB3-82A1-3B3BDFC26F65Q36238390-D4A2EAD2-5970-48B1-A3A9-ED9B2DFB884CQ36931357-376FCCE4-96FD-4370-BA15-5D96EA8378D5Q37181699-58872934-4822-4621-B7D5-54818B7C30D4Q37189322-B8E01A7E-02BA-4FD5-B303-EB8F6874728CQ37218206-7965EB1B-D0BA-4BEB-BC1A-7F8A0385D6DAQ37343475-A8CB99C2-3738-4F7B-BA7F-7E80E9E1AD5FQ37372285-91C0CC50-732E-4CEC-A2DB-9B06A7F3F1D5Q37549407-D5A1EB63-3435-4349-B442-3225A9A6DB50Q37595289-F4DBA9DC-D763-49DD-8D78-EEB93BE73EDAQ40020065-36ABED3D-12FF-4FA0-8A15-8B58242AE4B8Q42247648-DC8034B1-5F47-4DE1-87FC-8C790C0A1CCEQ45148080-747D00C4-A652-4BB1-80DC-DF67B64260D4Q52579005-63BE5961-DA5B-4BA5-B271-D30428AE6CE5
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Juvenile myelomonocytic leukemia and Noonan syndrome.
@ast
Juvenile myelomonocytic leukemia and Noonan syndrome.
@en
Juvenile myelomonocytic leukemia and Noonan syndrome.
@nl
type
label
Juvenile myelomonocytic leukemia and Noonan syndrome.
@ast
Juvenile myelomonocytic leukemia and Noonan syndrome.
@en
Juvenile myelomonocytic leukemia and Noonan syndrome.
@nl
prefLabel
Juvenile myelomonocytic leukemia and Noonan syndrome.
@ast
Juvenile myelomonocytic leukemia and Noonan syndrome.
@en
Juvenile myelomonocytic leukemia and Noonan syndrome.
@nl
P2093
P1476
Juvenile myelomonocytic leukemia and Noonan syndrome.
@en
P2093
P304
P356
10.1097/00043426-199911000-00015
P577
1999-11-01T00:00:00Z